Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

126 trials with published results (19%)

Research Maturity

493 completed trials (76% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.5%

42 terminated out of 647 trials

Success Rate

92.1%

+5.6% vs benchmark

Late-Stage Pipeline

26%

165 trials in Phase 3/4

Results Transparency

26%

126 of 493 completed with results

Key Signals

126 with results92% success42 terminated

Data Visualizations

Phase Distribution

483Total
Not Applicable (115)
Early P 1 (1)
P 1 (106)
P 2 (96)
P 3 (79)
P 4 (86)

Trial Status

Completed493
Terminated42
Unknown38
Withdrawn23
Recruiting23
Not Yet Recruiting16

Trial Success Rate

92.1%

Benchmark: 86.5%

Based on 493 completed trials

Clinical Trials (647)

Showing 20 of 20 trials
NCT07727642Not ApplicableRecruiting

Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma

NCT06908252Phase 4CompletedPrimary

MAPS PrEP Van Study

NCT04340596Phase 1Active Not RecruitingPrimary

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT02140255Phase 1RecruitingPrimary

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

NCT01322932CompletedPrimary

Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

NCT01621347CompletedPrimary

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

NCT01621412CompletedPrimary

HIV Disclosure and Medication Adherence, a Pilot Study

NCT07209267Phase 2Not Yet RecruitingPrimary

Baricitinib Curative Repression of HIV-1

NCT07704164Phase 2RecruitingPrimary

Colchicine to Reduce Coronary Artery Inflammation in People With HIV

NCT07695493Not ApplicableNot Yet RecruitingPrimary

An Open-label Randomized Trial Evaluating the Acceptability, Quality of Care, Patient Satisfaction, and Cost-effectiveness of Monitoring Provided by Nurses or Physicians for People Using HIV Pre-exposure Prophylaxis

NCT05077527Phase 1Recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

NCT07620652Not Yet RecruitingPrimary

Pilot Study to Evaluate Efficacy and Safety of Switching to BIC/FTC/TAF in PWH With a Previous Virological Failure Under CAB/RPV LAI

NCT02816879Not ApplicableActive Not Recruiting

Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men

NCT04265950Phase 4CompletedPrimary

Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial

NCT07681908Not ApplicableNot Yet Recruiting

#TranscendentHealth: A Text Messaging Pregnancy Prevention Program for Transgender Boys

NCT07678268Phase 4RecruitingPrimary

Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up

NCT07552038RecruitingPrimary

Dental Management of Patients With HIV in Pays de la Loire

NCT07042945Phase 1CompletedPrimary

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

NCT07658976Phase 3Not Yet RecruitingPrimary

Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy

NCT04929028Phase 2Active Not Recruiting

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Scroll to load more

Research Network

Activity Timeline